
Abivax SA: updates and filings
Price
$73.20
November 20, 2026Market cap $5.7B
What Ploutos Investor adds for Abivax SA
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from 2021
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Sep 21, 2026FilingFormF-6EF
- Sep 21, 2026Current report (foreign company)Form6-K
- Aug 14, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 6, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Jul 2, 2026Current report (foreign company)Form6-K
- Jun 30, 2026FilingFormPOSASR
- Jun 29, 2026Current report (foreign company)Form6-K
- Jun 2, 2026Current report (foreign company)Form6-K
- May 22, 2026Current report (foreign company)Form6-K
- May 20, 2026Current report (foreign company)Form6-K
- May 11, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- May 7, 2026Current report (foreign company)Form6-K
- Apr 20, 2026Current report (foreign company)Form6-K
- Mar 23, 2026Shares registered for employeesFormS-8
- Mar 23, 2026Annual report (foreign company)for the period to Dec 31, 2025Form20-F
- Mar 23, 2026Current report (foreign company)Form6-K
- Feb 23, 2026Current report (foreign company)Form6-K
- Feb 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 14, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Dec 15, 2025Current report (foreign company)Form6-K
- Nov 14, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 14, 2025Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 30, 2025Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Sep 21, 2026 | F-6EF | Filing | Document |
| Sep 21, 2026 | 6-K | Current report (foreign company) | Document |
| Aug 14, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 6, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Jul 2, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 30, 2026 | POSASR | Filing | Document |
| Jun 29, 2026 | 6-K | Current report (foreign company) | Document |
| Jun 2, 2026 | 6-K | Current report (foreign company) | Document |
| May 22, 2026 | 6-K | Current report (foreign company) | Document |
| May 20, 2026 | 6-K | Current report (foreign company) | Document |
| May 11, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| May 7, 2026 | 6-K | Current report (foreign company) | Document |
| Apr 20, 2026 | 6-K | Current report (foreign company) | Document |
| Mar 23, 2026 | S-8 | Shares registered for employees | Document |
| Mar 23, 2026 | 20-F | Annual report (foreign company)for the period to Dec 31, 2025 | Document |
| Mar 23, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 23, 2026 | 6-K | Current report (foreign company) | Document |
| Feb 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 14, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Dec 15, 2025 | 6-K | Current report (foreign company) | Document |
| Nov 14, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 14, 2025 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 30, 2025 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Dec 16, 2022.
The full analysis
What do Abivax SA's filings show?
The filings are where every one of Abivax SA's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.